Comparison of ondansetron, tropisetron, and palonosetron for the prevention of postoperative nausea and vomiting after middle ear surgery

Ahmet Aydin, Mustafa Kaçmaz, Adem Boyaci, Ahmet Aydin, Mustafa Kaçmaz, Adem Boyaci

Abstract

Background: Postoperative nausea and vomiting (PONV) are 2 of the most frequent adverse effects of anesthesia. PONV prolongs hospital stays and also delays the recovery of patients.

Objective: In this study, the effects of ondansetron, tropisetron, and palonosetron on PONV in patients who had undergone middle ear surgeries such as mastoidectomy or tympanoplasty were compared.

Methods: The study included 165 American Society of Anesthesiologists grade 1 and 2 patients aged 18 to 65 years. Patients were randomized into 3 groups by a closed envelope method. Neither the patients nor the nurses administering the treatments knew which patient belonged to which group. The anesthetic technique was standardized for all groups. During skin closure, 0.075 mg palonosetron, 5 mg tropisetron, and 8 mg ondansetron were administered intravenously to the palonosetron, tropisetron, and ondansetron groups, respectively. After completion of the surgery, the patients were followed for 48 hours. Diclofenac sodium (100 mg IM) was administered to patients experiencing pain and metoclopramide chloride (10 mg IM) was administered to patients with nausea or vomiting. Potential side effects such as headache and constipation were recorded in the postanesthesia care unit and ear, nose, and throat clinic.

Results: There was no significant difference in the effects of all 3 antiemetic agents on the severity of PONV (P = 0.081). At 48 hours postoperatively, the incidence of PONV was significantly lower in the palonosteron group (38.2%) than the ondansetron group (63.6%) and tropisetron group (61.8%) (P = 0.011). At 48 hours postoperatively, the incidence of postoperative nausea was significantly lower in the palonosetron group (32.7%) than in the ondansetron group (63.6%) and the tropisetron group (56.4%) (P = .003). The incidence of PONV between hours 12 and 24 postoperatively was significantly higher in the ondansetron group (27.3%) than in the palonosetron group (9.1%) (P = 0.013). The antiemetic requirement in the first hour after surgery was significantly higher in the tropisetron group (25.5%) than in the palonosetron group (7.3%) (P = .019).

Conclusions: The results of the current study support those of earlier studies that suggest that palonosetron was statistically more effective than the other 2 formulations in the prevention of PONV in patients who have undergone middle ear surgery. (Curr Ther Res Clin Exp. 2019; 80:XXXXXX).

Keywords: Ear; Nausea; Ondansetron; Palonosetron; Tropisetron; Vomiting.

References

    1. Watcha M.F., White P.F. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology. 1992;77:162–184.
    1. Murphy M.J., Hooper V.D., Sullivan E., Clifford T., Apfel C.C. Identification of risk factors for postoperative nausea and vomiting in the perianesthesia adult patient. Journal of perianesthesia Nursing. 2006;21:377–384.
    1. Kovac A.L. Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists. Journal of clinical anesthesia. 2006;18:304–318.
    1. Lipp A., Kaliappan A. Focus on quality: managing pain and PONV in day surgery. Current Anaesthesia & Critical Care. 2007;18:200–207.
    1. Ho K.-Y., Gan T.J. Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Current Opinion in Anesthesiology. 2006;19:606–611.
    1. Gan T.J., Meyer T., Apfel C.C., Chung F., Davis P.J., Eubanks S., Kovac A., Philip B.K., Sessler D.I., Temo J. Consensus guidelines for managing postoperative nausea and vomiting. Anesthesia & Analgesia. 2003;97:62–71.
    1. Leon A.D. Palonosetron (Aloxi): a second-generation 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting, Baylor University Medical Center Proceedings. Taylor & Francis; 2006. pp. 413–416.
    1. Tramer M. A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part I. Efficacy and harm of antiemetic interventions, and methodological issues. Acta Anaesthesiologica Scandinavica. 2001;45:4–13.
    1. Aspinall R.L., Goodman N.W. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. Bmj. 1995;311:844–846.
    1. Apfel C., Roewer N., Korttila K. How to study postoperative nausea and vomiting. Acta Anaesthesiologica Scandinavica. 2002;46:921–928.
    1. Jellish W.S., Thalji Z., Fluter E., Leonetti J.P. Ondansetron versus droperidol or placebo when given prophylactically for the prevention of postoperative nausea and vomiting in patients undergoing middle ear procedures. Journal of clinical anesthesia. 1997;9:451–456.
    1. Fujii Y., Saitoh Y., Tanaka H., Toyooka H. Elsevier; 1999. RETRACTED: Combination of granisetron and droperidol in the prevention of nausea and vomiting after middle ear surgery.
    1. Hasan R.A., LaRouere M.J., Kartush J., Bojrab D. Ambulatory tympanomastoid surgery in children: factors affecting hospital admission. Archives of Otolaryngology–Head & Neck Surgery. 2004;130:1158–1162.
    1. Sadhasivam S., Shende D., Madan R. Prophylactic Ondansetron in Prevention of Postoperative Nausea and Vomiting following Pediatric Strabismus SurgeryA Dose–Response Study. Anesthesiology: The Journal of the American Society of Anesthesiologists. 2000;92:1035–1042.
    1. Golembiewski J., Tokumaru S. Pharmacological prophylaxis and management of adult postoperative/postdischarge nausea and vomiting. Journal of PeriAnesthesia Nursing. 2006;21:385–397.
    1. Jordan K., Schmoll H.J., Aapro M.S. Comparative activity of antiemetic drugs. Critical reviews in oncology/hematology. 2007;61:162–175.
    1. Carlisle J., Stevenson C.A. Drugs for preventing postoperative nausea and vomiting. Cochrane database of systematic reviews. 2006
    1. Fujii Y., Toyooka H., Tanaka H. Granisetron in the prevention of nausea and vomiting after middle-ear surgery: a dose-ranging study. British journal of anaesthesia. 1998;80:764–766.
    1. Khalil S., Philbrook L., Rabb M., Wells L., Aves T., Villanueva G., Amhan M., Chuang A.Z., Lemak N.A. Ondansetron/promethazine combination or promethazine alone reduces nausea and vomiting after middle ear surgery. Journal of clinical anesthesia. 1999;11:596–600.
    1. Madenoglu H., Yildiz K., Dogru K., Kurtsoy A., Güler G., Boyaci A. Randomized, double-blinded comparison of tropisetron and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. Journal of neurosurgical anesthesiology. 2003;15:82–86.
    1. Hsu E.S. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. American journal of therapeutics. 2010;17:476–486.
    1. Gralla R., Lichinitser M., Van Der Vegt S., Sleeboom H., Mezger J., Peschel C., Tonini G., Labianca R., Macciocchi A., Aapro M. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Annals of Oncology. 2003;14:1570–1577.
    1. Kazemi-Kjellberg F., Henzi I., Tramèr M.R. Treatment of established postoperative nausea and vomiting: a quantitative systematic review. BMC anesthesiology. 2001;1:2.
    1. Rojas C., Stathis M., Thomas A.G., Massuda E.B., Alt J., Zhang J., Rubenstein E., Sebastiani S., Cantoreggi S., Snyder S.H. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. Anesthesia & Analgesia. 2008;107:469–478.
    1. Singh P.M., Borle A., Gouda D., Makkar J.K., Arora M.K., Trikha A., Sinha A., Goudra B. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)—a meta-analysis. Journal of clinical anesthesia. 2016;34:459–482.
    1. Li Y., Wei X., Zhang S., Zhou L., Zhang J. A meta-analysis of palonosetron for the prevention of postoperative nausea and vomiting in adults. Journal of PeriAnesthesia Nursing. 2015;30:398–405.
    1. Myles P., Williams D., Hendrata M., Anderson H., Weeks A. Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients. British journal of anaesthesia. 2000;84:6–10.
    1. Gan T.J., Diemunsch P., Habib A.S., Kovac A., Kranke P., Meyer T.A., Watcha M., Chung F., Angus S., Apfel C.C. Consensus guidelines for the management of postoperative nausea and vomiting. Anesthesia & Analgesia. 2014;118:85–113.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe